Format

Send to

Choose Destination
Cancer Cell. 2009 Jul 7;16(1):1-2. doi: 10.1016/j.ccr.2009.06.010.

Breast cancer SRC activity: bad to the bone.

Author information

1
Center for Cancer Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02129, USA. dsgroi@partners.org

Abstract

Bone metastases are a major cause of breast cancer morbidity and mortality. In this issue of Cancer Cell, Zhang and colleagues identify a Src activation expression signature associated with late-onset breast cancer bone metastases and provide evidence for Src as a key mediator of survival signals in latent bone metastases.

PMID:
19573804
DOI:
10.1016/j.ccr.2009.06.010
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center